These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 17983807)

  • 21. An adaptive mutation in NS2 is essential for efficient production of infectious 1b/2a chimeric hepatitis C virus in cell culture.
    Chan K; Cheng G; Beran RK; Yang H; Appleby TC; Pokrovskii MV; Mo H; Zhong W; Delaney WE
    Virology; 2012 Jan; 422(2):224-34. PubMed ID: 22099378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell culture and infection system for hepatitis C virus.
    Kato T; Date T; Murayama A; Morikawa K; Akazawa D; Wakita T
    Nat Protoc; 2006; 1(5):2334-9. PubMed ID: 17406476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel infectious cDNA clones of hepatitis C virus genotype 3a (strain S52) and 4a (strain ED43): genetic analyses and in vivo pathogenesis studies.
    Gottwein JM; Scheel TK; Callendret B; Li YP; Eccleston HB; Engle RE; Govindarajan S; Satterfield W; Purcell RH; Walker CM; Bukh J
    J Virol; 2010 May; 84(10):5277-93. PubMed ID: 20200247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential sensitivity of 5'UTR-NS5A recombinants of hepatitis C virus genotypes 1-6 to protease and NS5A inhibitors.
    Li YP; Ramirez S; Humes D; Jensen SB; Gottwein JM; Bukh J
    Gastroenterology; 2014 Mar; 146(3):812-821.e4. PubMed ID: 24262279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The p7 polypeptide of hepatitis C virus is critical for infectivity and contains functionally important genotype-specific sequences.
    Sakai A; Claire MS; Faulk K; Govindarajan S; Emerson SU; Purcell RH; Bukh J
    Proc Natl Acad Sci U S A; 2003 Sep; 100(20):11646-51. PubMed ID: 14504405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis C virus: an infectious molecular clone of a second major genotype (2a) and lack of viability of intertypic 1a and 2a chimeras.
    Yanagi M; Purcell RH; Emerson SU; Bukh J
    Virology; 1999 Sep; 262(1):250-63. PubMed ID: 10489358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A recombinant replication-competent hepatitis C virus expressing Azami-Green, a bright green-emitting fluorescent protein, suitable for visualization of infected cells.
    Hou W; Aoki C; Yu L; Wen X; Xue Y; Gao B; Liu W; Gao GF; Iwamoto A; Kitamura Y
    Biochem Biophys Res Commun; 2008 Dec; 377(1):7-11. PubMed ID: 18786508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A point mutation at Asn-534 that disrupts a conserved N-glycosylation motif of the E2 glycoprotein of hepatitis C virus markedly enhances the sensitivity to antibody neutralization.
    Sasayama M; Shoji I; Adianti M; Jiang DP; Deng L; Saito T; Watanabe H; Kawata S; Aoki C; Hotta H
    J Med Virol; 2012 Feb; 84(2):229-34. PubMed ID: 22170542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incorporation of primary patient-derived glycoproteins into authentic infectious hepatitis C virus particles.
    Doerrbecker J; Friesland M; Riebesehl N; Ginkel C; Behrendt P; Brown RJ; Ciesek S; Wedemeyer H; Sarrazin C; Kaderali L; Pietschmann T; Steinmann E
    Hepatology; 2014 Aug; 60(2):508-20. PubMed ID: 24771613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An in vitro model of hepatitis C virus genotype 3a-associated triglycerides accumulation.
    Abid K; Pazienza V; de Gottardi A; Rubbia-Brandt L; Conne B; Pugnale P; Rossi C; Mangia A; Negro F
    J Hepatol; 2005 May; 42(5):744-51. PubMed ID: 15826725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Highly efficient full-length hepatitis C virus genotype 1 (strain TN) infectious culture system.
    Li YP; Ramirez S; Jensen SB; Purcell RH; Gottwein JM; Bukh J
    Proc Natl Acad Sci U S A; 2012 Nov; 109(48):19757-62. PubMed ID: 23151512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isolation of JFH-1 strain and development of an HCV infection system.
    Wakita T
    Methods Mol Biol; 2009; 510():305-27. PubMed ID: 19009271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Replication and infectivity of a novel genotype 1b hepatitis C virus clone.
    Date T; Morikawa K; Tanaka Y; Tanaka-Kaneko K; Sata T; Mizokami M; Wakita T
    Microbiol Immunol; 2012 May; 56(5):308-17. PubMed ID: 22320232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell culture adaptation of hepatitis C virus and in vivo viability of an adapted variant.
    Kaul A; Woerz I; Meuleman P; Leroux-Roels G; Bartenschlager R
    J Virol; 2007 Dec; 81(23):13168-79. PubMed ID: 17881454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of full-length cell-culture infectious clone and subgenomic replicon for a genotype 3a isolate of hepatitis C virus.
    Chen M; Xu Y; Li N; Yin P; Zhou Q; Feng S; Wu T; Wei L; Wang H; Fu Y; Li YP
    J Gen Virol; 2021 Dec; 102(12):. PubMed ID: 34949310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acquisition of susceptibility to hepatitis C virus replication in HepG2 cells by fusion with primary human hepatocytes: establishment of a quantitative assay for hepatitis C virus infectivity in a cell culture system.
    Ito T; Yasui K; Mukaigawa J; Katsume A; Kohara M; Mitamura K
    Hepatology; 2001 Sep; 34(3):566-72. PubMed ID: 11526543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IL-6-mediated intersubgenotypic variation of interferon sensitivity in hepatitis C virus genotype 2a/2b chimeric clones.
    Suda G; Sakamoto N; Itsui Y; Nakagawa M; Tasaka-Fujita M; Funaoka Y; Watanabe T; Nitta S; Kiyohashi K; Azuma S; Kakinuma S; Tsuchiya K; Imamura M; Hiraga N; Chayama K; Watanabe M
    Virology; 2010 Nov; 407(1):80-90. PubMed ID: 20797756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum-derived hepatitis C virus infectivity in interferon regulatory factor-7-suppressed human primary hepatocytes.
    Aly HH; Watashi K; Hijikata M; Kaneko H; Takada Y; Egawa H; Uemoto S; Shimotohno K
    J Hepatol; 2007 Jan; 46(1):26-36. PubMed ID: 17112629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The variable regions of hepatitis C virus glycoprotein E2 have an essential structural role in glycoprotein assembly and virion infectivity.
    McCaffrey K; Gouklani H; Boo I; Poumbourios P; Drummer HE
    J Gen Virol; 2011 Jan; 92(Pt 1):112-21. PubMed ID: 20926639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficient Hepatitis C Virus Genotype 1b Core-NS5A Recombinants Permit Efficacy Testing of Protease and NS5A Inhibitors.
    Pham LV; Ramirez S; Carlsen THR; Li YP; Gottwein JM; Bukh J
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28348150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.